A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors
We identified a novel gene signature with strong prognostic value in prostate cancer and potential relevance to male BC. This gene signature represents a complementary tool to standard clinical parameters for improving patient stratification and management.
Authors
- Rosamaria Lappano (ORCID: https://orcid.org/0000-0002-9374-9701)
- Azzurra Zicarelli
- Francesca Cirillo (ORCID: https://orcid.org/0000-0003-2183-4226)
- Marianna Talia (ORCID: https://orcid.org/0000-0002-3440-5618)
- Domenica Scordamaglia (ORCID: https://orcid.org/0000-0001-8384-4230)
- Anna Miglietta
- Marcello Maggiolini (ORCID: https://orcid.org/0000-0002-7485-854X)
- Ernestina Marianna De Francesco (ORCID: https://orcid.org/0000-0002-2810-6128)
- Roberta Malaguarnera (ORCID: https://orcid.org/0000-0003-4149-9488)
- Eugenio Cesario
Institutions
- Università degli Studi di Enna Kore (IT)
- Ospedale Annunziata di Cosenza (IT)
- University of Calabria (IT)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1186/s12967-025-07196-6
- Primary Topic
- Male Breast Health Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Associazione Italiana per la Ricerca sul Cancro